U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07785492) titled 'Artificial Intelligence Support for Stroke' on Aug. 15.

Brief Summary: This study investigates whether an AI-assisted decision support tool, compared with standard care, increases the proportion of acute ischemic stroke patients receiving intravenous thrombolysis within 24 hours of symptom onset at a primary hospital in China, while also evaluating its impact on clinical outcomes, treatment timelines, and safety.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Ischemic Stroke, Acute

Intervention: OTHER: AI-assisted thrombolysis decision support

The AI-assisted thrombolysis decision support tool is used by att...